PULMONX CORP (LUNG) insider trading activity (SEC Form 4). Over the trailing 90 days, LUNG insiders filed 0 purchases totalling $0 and 4 sales totalling $144K — net SELLING of $144K. Most recent filing: Jun 3, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | French Glendon E. III | Pres, CEO | S Sale | — | $1.55 | $87K | filing |
| Jun 3, 2026 | Rose Geoffrey Beran | Chief Commercial Officer | S Sale | — | $1.54 | $12K | filing |
| Jun 3, 2026 | Lehman David Aaron | GC | S Sale | — | $1.54 | $22K | filing |
| Jun 3, 2026 | Radhakrishnan Srikanth | Chief Science,Techn. Officer | S Sale | — | $1.54 | $22K | filing |